AU684877B2 - Indoline derivatives, method of preparation and their use as pharmaceuticals - Google Patents

Indoline derivatives, method of preparation and their use as pharmaceuticals Download PDF

Info

Publication number
AU684877B2
AU684877B2 AU12743/95A AU1274395A AU684877B2 AU 684877 B2 AU684877 B2 AU 684877B2 AU 12743/95 A AU12743/95 A AU 12743/95A AU 1274395 A AU1274395 A AU 1274395A AU 684877 B2 AU684877 B2 AU 684877B2
Authority
AU
Australia
Prior art keywords
formula
compound
compounds
international
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU12743/95A
Other languages
English (en)
Other versions
AU1274395A (en
Inventor
Malcolm Clive Carter
Peter Charles North
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1274395A publication Critical patent/AU1274395A/en
Application granted granted Critical
Publication of AU684877B2 publication Critical patent/AU684877B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU12743/95A 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals Ceased AU684877B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939326192A GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds
GB9326192 1993-12-22
PCT/EP1994/004220 WO1995017405A1 (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals

Publications (2)

Publication Number Publication Date
AU1274395A AU1274395A (en) 1995-07-10
AU684877B2 true AU684877B2 (en) 1998-01-08

Family

ID=10747030

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12743/95A Ceased AU684877B2 (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and their use as pharmaceuticals

Country Status (15)

Country Link
US (1) US5633276A (online.php)
EP (1) EP0736028A1 (online.php)
JP (1) JPH09507057A (online.php)
AP (1) AP535A (online.php)
AU (1) AU684877B2 (online.php)
CA (1) CA2179402A1 (online.php)
CO (1) CO4340623A1 (online.php)
GB (1) GB9326192D0 (online.php)
IL (1) IL112097A (online.php)
IS (1) IS4244A (online.php)
MY (1) MY131641A (online.php)
SV (1) SV1994000083A (online.php)
TW (1) TW291479B (online.php)
WO (1) WO1995017405A1 (online.php)
ZA (1) ZA9410056B (online.php)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
CA2241666C (en) * 1996-03-08 2007-11-06 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
EP1199304A1 (en) * 1997-03-05 2002-04-24 Takeda Chemical Industries, Ltd. Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders
RU2190609C2 (ru) * 1996-12-10 2002-10-10 Бристол-Маерс Сквибб Компани Производные бензодиоксола, бензофурана, дигидробензофурана и бензодиоксана и содержащие их композиции
US5948817A (en) * 1997-03-05 1999-09-07 Bristol-Myers Squibb Company Polycyclic ethyl alkylamide melatonergic agents
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU727654B2 (en) * 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
EP1082115A4 (en) * 1998-06-05 2002-10-24 Bristol Myers Squibb Co MELATONERGICS BASED ON HETEROCYCLIC CIS DERIVATIVES OF CYCLOPROPANE
ES2213022T3 (es) 1999-06-30 2004-08-16 Bristol-Myers Squibb Company Derivados de aminopirrolidina heterociclicos utiles como agentes melatonergicos.
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
WO2001014385A1 (en) 1999-08-20 2001-03-01 Takeda Chemical Industries, Ltd. Dihydrobenzofuran derivatives, process for the preparation thereof and agents
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
DK1268482T3 (da) * 2000-03-17 2003-12-22 Alcon Inc Pyranoindoler til behandling af glaukom
ES2172415B2 (es) 2000-07-28 2003-11-16 Univ Madrid Complutense Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
US6743448B2 (en) * 2000-12-11 2004-06-01 Abraham H. Kryger Topical testosterone formulations and associated methods
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
CA2644181A1 (en) * 2006-03-20 2007-09-27 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for irritable bowel syndrome
WO2008069311A1 (ja) 2006-12-08 2008-06-12 Takeda Pharmaceutical Company Limited 三環性化合物およびその医薬用途
ES2331274B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuesto de indolina.
MX2011001062A (es) * 2008-07-30 2011-03-24 Ferrer Int Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno.
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043752A1 (fr) * 1980-06-26 1982-01-13 SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: Dérivé de pyranno-indole et son procédé de préparation
EP0207605A1 (en) * 1985-05-21 1987-01-07 Pfizer Inc. Hypoglycemic thiazolidinediones

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043752A1 (fr) * 1980-06-26 1982-01-13 SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: Dérivé de pyranno-indole et son procédé de préparation
EP0207605A1 (en) * 1985-05-21 1987-01-07 Pfizer Inc. Hypoglycemic thiazolidinediones

Also Published As

Publication number Publication date
IL112097A (en) 1998-06-15
JPH09507057A (ja) 1997-07-15
IS4244A (is) 1995-06-23
AP9400706A0 (en) 1995-01-31
AP535A (en) 1996-09-16
WO1995017405A1 (en) 1995-06-29
SV1994000083A (es) 1995-07-24
EP0736028A1 (en) 1996-10-09
GB9326192D0 (en) 1994-02-23
TW291479B (online.php) 1996-11-21
MY131641A (en) 2007-08-30
AU1274395A (en) 1995-07-10
ZA9410056B (en) 1995-10-18
CA2179402A1 (en) 1995-06-29
US5633276A (en) 1997-05-27
IL112097A0 (en) 1995-03-15
CO4340623A1 (es) 1996-07-30

Similar Documents

Publication Publication Date Title
AP535A (en) Indoline derivatives, method of preparation and use.
US5455252A (en) Optionally substituted 6,8-quinolines
JP2941309B2 (ja) 化合物
AU679053B2 (en) Indoletetralins having dopaminergic activity
KR930003759B1 (ko) 인돌 유도체의 제조방법
JP3033076B2 (ja) カンナビノイド受容体への親和性を有するインドール誘導体
JP2000515136A (ja) プロテインチロシンキナーゼ阻害剤としての二環式ヘテロ芳香族化合物
KR20000023812A (ko) 단백질 티로신 키나제의 억제제인 비시클릭 헤테로방향족 화합물
IE57809B1 (en) 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
JPH08504785A (ja) 5−ht▲下1▼様アゴニストとしてのトリプタミンアナログ
FR2596049A1 (fr) Derives de dichloroaniline
JPH10502336A (ja) ナフタレン誘導体、製造方法および使用
JP2007277254A (ja) 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体
JPH08512299A (ja) 5ht▲下2c▼アンタゴニストとしてのインドリン誘導体
JP2000511518A (ja) 時間生物学的薬剤としてのベンゾフランおよびベンゾピラン
US6153641A (en) Pharmaceutically active compounds
JPH11508283A (ja) ベンゾフリル誘導体類及びそれらの用途
EP2040703B1 (fr) Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
FR2567510A1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
CH667454A5 (fr) Derives d'indoles.
JPS62195363A (ja) 化学化合物
JP2941333B2 (ja) インドール誘導体
US5770611A (en) Indole derivatives as 5HT1 -like agonists
US4221788A (en) 2-(Optionally-substituted)benzylperhydroazepines for analgesia and lowering blood pressure
JP2791069B2 (ja) シクロオクタン神経保護剤

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired